PRRT2 and neoplasm: Targeting PRRT2 is bryostatin, a powerful protein kinase C agonist that was originally developed to prevent tumor growth, but in preclinical studies has also shown promising effects as a restorative synapse drug that is currently in trials to treat Alzheimer’s disease44.